Erin M. Dickey, MD, MBS

Post Doctoral Fellow
Department of Surgery, University of Miami Miller School of Medicine, United States

Presentation(s):

• 44: Utility of circulating tumor DNA (ctDNA) for detection of minimal residual disease (MRD) after curative-intent therapy in localized pancreatic cancer (PDAC)

  Thursday, March 21, 2024
  2:22pm – 2:32pm ET

• P32: JNK inhibition reprograms the tumor-immune-microenvironment to overcome chemoresistance in PDAC

  Friday, March 22, 2024
  11:43am – 11:49am ET

• 56: Disrupting TNFR2 Signaling Improves Chemotherapy sensitivity in Pancreatic Cancer

  Saturday, March 23, 2024
  9:02am – 9:12am ET